Mangalam Drugs and Organics share news and announcements

NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap

₹28.65₹0.92 (3.11%)BSE ₹28.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.

52-week range of traded prices to 23 Oct 2026

₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025

Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹45 Cr3,423rd largest listed
P/E: Lossover the last 12 months
P/B: 0.4
Dividend yield: Nonein the last 12 months
ROE: −30.3%
ROCE: −12.9%
Debt to equity: 1.02
Volume, NSE: 19,55176.4% delivered

Mangalam Drugs and Organics board meetings

149 filed, newest first. Page 3 of 3.

Jun 2016
- 2 Jun · Board meeting
  10-Jun-2016 : The Company had informed the Exchange regarding the Board Meeting to be held on June 06, 2016 to inter alia consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, ( Promoter or Proposed Allottee ) on September 28, 2015 and the issue of which was approved by the shareholders at Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. The company has now inform the exchange that due to unavoidable circumstances the meeting of Board of Directors is postponed and re-scheduled to June 10, 2016. (opens in a new tab)
May 2016
- 26 May · Board meeting
  To inter alia consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, ( Promoter or Proposed Allottee ) on September 28, 2015 and the issue of which was approved by the shareholders at Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. (opens in a new tab)
- 16 May · Board meeting
  Board of Directors at their Meeting held on May 16, 2016 has transacted the following business:(1) Appointment of Ms. Anuradha Sukhani as Additional Director on the Board of the Company with effect from May 16, 2016. She will be Non executive Independent Director of the Company.(2) Accepted the Resignation of Ms. Meenal Sukhani, Director of the company with effect from the closure of Business hours on May 16, 2016.(3) Other Business transacted with permission of chair. (opens in a new tab)
- 6 May · Board meeting
  Inter-alia to consider, approve and take on record the following:1. To consider and take on record the Audited Financial Results for the quarter and year ended March 31, 20162. Any other matters with the permission of the chair (opens in a new tab)
Jan 2016
- 5 Jan · Board meeting
  Inter alia to consider and take on record the following : (1) . To consider and take on record the Unaudited Financial Results for the quarter and nine months ended December 31, 2015 (2).To appoint the Internal Auditor of the company for the financial year 2015-2016;(3) To appoint the Secretarial Auditor of the company for the financial year 2015-16.(4).Any other matters with the permission of the chair. (opens in a new tab)
Nov 2015
- 16 Nov · Board meeting
  Board of Directors at their Meeting held on November 16, 2015, inter alia transacted the following business:Approval of allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share warrants of Rs. 10/- each at a premium of Rs. 55/- per share out of the total 26,50,000 Warrants allotted to promoter group on preferential basis, upon the receipt of balance consideration amount on it. (opens in a new tab)
- 6 Nov · Board meeting
  To inter alia consider and approve the allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share Warrants which were allotted on preferential basis to Shri.JB Pharma LLP, ("Promoter" or "Proposed Allottee") on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. (opens in a new tab)
Oct 2015
- 21 Oct · Board meeting
  Board of Directors at their meeting held on October 21, 2015, have designated Mr. Brijmohan M Dhoot an existing Executive Director of the Company as the Non-Executive Director of the Company with immediate effect. (opens in a new tab)
- 13 Oct · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2015 and any other matter with the permission ofthe chair. (opens in a new tab)
Sep 2015
- 7 Sep · Board meeting
  Board of Directors at their Meeting held on September 04, 2015 has transacted the following business:(1) The Board of Directors have appointed Mr. Brijmohan M Dhoot who is an existing non Executive Director of the Company as the Whole Time Director of the Company w.e.f September 05, 2015. (opens in a new tab)
Aug 2015
- 6 Aug · Board meeting
  Outcome of Board Meeting of the Company held on August 6, 2015. (opens in a new tab)
- 4 Aug · Board meeting
  To inter alia consider and approve the issue of such number of Warrants or other securities convertible into equity shares or other securities convertible into equity shares on preferential basis to Shri.JB Pharma LLP, ( Promoter or Proposed Allottee ) subject to the approval of the Members, in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. (opens in a new tab)
Jul 2015
- 27 Jul · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2015. (opens in a new tab)
May 2015
- 5 May · Board meeting
  To consider annual audited financial results for the year ended on March 31, 2015.
Jan 2015
- 14 Jan · Board meeting
  Inter-alia to consider and take on record Unaudited Financial results for the Quater ended December 31,2014.
Nov 2014
- 4 Nov · Board meeting
  Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2014.
- 3 Nov · Board meeting
  At the Board meeting of the Company held on October 31, 2014 inter-alia following matters have been approved by the Board: 1. Re-appointment of Shri. Govardhan M. Dhoot as the Whole time Director of the Company for a period of five years w.e.f. November 01, 2014. 2. Mr. Ajay Samant working with the Company as Vice President (Finance) designated as the Chief Financial Officer pursuant to the requirement under Section 203 of the Companies Act, 2013.
Aug 2014
- 1 Aug · Board meeting
  Inter Alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2014. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from July 28, 2014 and would open 24 hours after the announcement of financial results to the public.
May 2014
- 21 May · Board meeting
  Inter alia, to transact following business: (1) To consider and approve the audited quarterly financial results of the Company for the quarter ended March 31, 2014, the audited financial results of the Company for the financial year ended March 31, 2014. Further in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company6 will be closed for all directors, officers and designated employees of the Company from May 15, 2014 and would open 24 hours after announcement of financial result to the public.
Jan 2014
- 28 Jan · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2013.
Nov 2013
- 5 Nov · Board meeting
  Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2013
Aug 2013
- 5 Aug · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2013.
May 2013
- 10 May · Board meeting
  To consider and approve the audited financial results for the year ended March 31, 2013.
Feb 2013
- 1 Feb · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2012.
Nov 2012
- 1 Nov · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2012.
Aug 2012
- 6 Aug · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2012.
Jul 2012
- 17 Jul · Board meeting
  Inter-alia to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend dividend, if any
May 2012
- 11 May · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended March 31, 2012.
Feb 2012
- 2 Feb · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2011.
Aug 2011
- 3 Aug · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2011.
May 2011
- 14 May · Board meeting
  Inter alia, to consider and approve the Audited Financial Results for the year ended March 31, 2011 and to recommend dividend, if any.
Feb 2011
- 2 Feb · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2010.
Oct 2010
- 29 Oct · Board meeting
  Company had informed the Exchange regarding the meeting of the Board of Directors of the Company was scheduled to be held on October 30, 2010 Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2010. The Company has now informed the Exchange that the aforesaid board meeting has been postponed to November 12, 2010.
  Not held on this date
- 18 Oct · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2010.
Jul 2010
- 15 Jul · Board meeting
  Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2010.
May 2010
- 21 May · Board meeting
  Inter alia, to consider and take on record the audited financial results and accounts for the year ended on March 31, 2010.
Jan 2010
- 14 Jan · Board meeting
  Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
- 21 Oct · Board meeting
  Meeting on 28 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
- 21 Jul · Board meeting
  Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
- 10 Jun · Board meeting
  Inter alia to Consider and take on record audited financial results and accounts for the year ended on March 31, 2009.
Jan 2009
- 14 Jan · Board meeting
  Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
- 15 Oct · Board meeting
  Meeting on 24 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Jul 2008
- 22 Jul · Board meeting
  Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
- 9 Jun · Board meeting
  Inter-alia to: (1). consider and take on record audited financial results and accounts for the year ended on March 31, 2008.
Jan 2008
- 18 Jan · Board meeting
  Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
- 9 Oct · Board meeting
  Meeting on 29 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
- 20 Jul · Board meeting
  Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
- 19 Jun · Board meeting
  Inter-alia to: 1) Consider and take on record audited financial results and accounts for the year ended on March 31, 2007. 2) Consider declaration of final dividend, if any.
Jan 2007
- 27 Jan · Board meeting
  Meeting on 30 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”

Mangalam Drugs and Organics board meetings

Jun 2016

May 2016

Jan 2016

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

May 2015

Jan 2015

Nov 2014

Aug 2014

May 2014

Jan 2014

Nov 2013

Aug 2013

May 2013

Feb 2013

Nov 2012

Aug 2012

Jul 2012

May 2012

Feb 2012

Aug 2011

May 2011

Feb 2011

Oct 2010

Jul 2010

May 2010

Jan 2010

Oct 2009

Jul 2009

Jun 2009

Jan 2009

Oct 2008

Jul 2008

Jun 2008

Jan 2008

Oct 2007

Jul 2007

Jun 2007

Jan 2007